We could not find any results for:
Make sure your spelling is correct or try broadening your search.
1250 GMT - Merck is among the most mentioned companies across news items over the past 12 hours, according to Factiva data, after the German pharmaceutical-and-chemical group said its multiple...
By Helena Smolak Shares of Germany's Merck KGaA plunged after its experimental drug evobrutinib failed in two late-stage trials of patients with relapsing forms of multiple sclerosis. At 0927...
By David Sachs Merck's multiple sclerosis drug evobrutinib didn't meet a key goal in late-stage trials. The German pharmaceutical company's phase 3 clinical trials for the drug did...
By David Sachs Merck has a deal worth at least $70 million with Abbisko Therapeutics to commercialize a drug to treat joint tumors. The German pharmaceutical company said Monday that its deal with...
By Adria Calatayud Germany's Merck KGaA expects earnings and sales for 2023 to be at the lower half of its outlook ranges, after reporting lower third-quarter revenue across all segments. The...
By Helena Smolak Germany's Merck KGaA is contemplating job cuts within its electronics division as part of a cost-saving initiative prompted by a market downturn that is lasting longer than...
By Adria Calatayud Germany's Merck KGaA has entered into a partnership to license a cancer drug developed by China's Jiangsu Hengrui Pharmaceuticals for up to 1.4 billion euros ($1.48...
By Adria Calatayud Shares of Germany's Merck KGaA rose after the company forecast a return to organic sales growth next year, supported by recovering demand for semiconductor materials and...
By Adria Calatayud Germany's Merck KGaA expects to return to organic sales growth next year after a broadly flat performance in 2023, helped by reduced Covid-19 headwinds and recovering...
By Colin Kellaher Shares of Exscientia rose sharply in premarket trading Wednesday after the precision-medicine company formed an artificial-intelligence collaboration potentially worth hundreds...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.99 | -3.33221137664 | 29.71 | 29.73 | 28.29 | 210043 | 29.1454797 | DR |
4 | -0.38 | -1.3058419244 | 29.1 | 30.48 | 28.29 | 149246 | 29.54101451 | DR |
12 | -7.29 | -20.2443765621 | 36.01 | 36.16 | 28.29 | 104091 | 31.15576784 | DR |
26 | -6.96 | -19.5067264574 | 35.68 | 39.17 | 28.29 | 67159 | 32.3007761 | DR |
52 | -2.188 | -7.07907337906 | 30.908 | 39.17 | 28.29 | 74587 | 32.81774381 | DR |
156 | -21.41 | -42.7089567125 | 50.13 | 52.29 | 28.29 | 75140 | 34.99146845 | DR |
260 | 5.57 | 24.060475162 | 23.15 | 52.29 | 16.55 | 73984 | 33.02735484 | DR |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions